Nasdaq: TXG

10x Genomics, Inc. (TXG)

10x Genomics, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker TXG. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
TXG
Exchange
Nasdaq
SEC CIK
1770787
Official filings
SEC EDGAR

Research TXG

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is 10x Genomics, Inc.'s stock ticker?

10x Genomics, Inc. trades under the ticker symbol TXG on Nasdaq. Its SEC Central Index Key (CIK) is 1770787.

Where can I read 10x Genomics, Inc.'s SEC filings?

The TXG SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports 10x Genomics, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze TXG's financial statements?

The TXG Financials page shows 10x Genomics, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does TXG compare with its peers and the market?

The TXG Peer Comparison page lines 10x Genomics, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.